Dexcom (DXCM) valuation history
Historically low
As of
DXCM's EV/EBITDA of 22.4x is lower than 95% of its available weekly readings from the last five years.
Share EV/EBITDA history
Chart by stockresearch.app. Reuse with credit under CC BY 4.0.
EV/EBITDA at year-end
Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.
| Reading date | EV/EBITDA | 5-year rank |
|---|---|---|
| 25.9× | 3% | |
| 39.8× | 9% | |
| 77.2× | 10% | |
| 114.4× | 38% | |
| 123.9× | 41% | |
| 105.5× | 17% | |
| Unavailable | Short history | |
| 680.6× | Short history | |
| Unavailable | Short history | |
| Unavailable | Short history |
Loading related research…
About this history
- What is DXCM's current EV/EBITDA?
- DXCM's EV/EBITDA of 22.4x is lower than 95% of its available weekly readings from the last five years.
- What is DXCM's five-year median EV/EBITDA?
- The median, or middle weekly reading, is 60.0× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
- Does a low historical rank mean a stock is a buy?
- No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.